NCT05396716

Brief Summary

Incidence of postoperative nausea and vomiting (PONV) could be high as 60% after liver surgery. Acupoint stimulation has been proved to decrease PONV. In this study, we will investigate the effect of transcutaneous electrical acupoint stimulation on incidence of PONV after liver surgery.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

May 30, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 31, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
Last Updated

May 31, 2022

Status Verified

May 1, 2022

Enrollment Period

1 year

First QC Date

May 25, 2022

Last Update Submit

May 25, 2022

Conditions

Keywords

transcutaneous electrical acupoint stimulationliver surgery

Outcome Measures

Primary Outcomes (1)

  • incidence of nausea and vomiting by 24 hours after surgery

    from end of surgery to 24 hours after surgery, in a total of 24 hours

Secondary Outcomes (9)

  • incidence of nausea and vomiting by 48 hours after surgery

    from end of surgery to 48 hours after surgery, in a total of 48 hours

  • incidence of nausea and vomiting in PACU (post-anesthesia care unit)

    from end of surgery to discharge from PACU(post-anesthesia care unit), in an average of 30 minutes

  • score of nausea and vomiting by 24 hours after surgery

    from end of surgery to 24 hours after surgery, in a total of 24 hours

  • score of nausea and vomiting by 48 hours after surgery

    from end of surgery to 48 hours after surgery, in a total of 48 hours

  • score of nausea and vomiting in PACU(post-anesthesia care unit)

    from end of surgery to discharge from PACU, in an average of 30 minutes

  • +4 more secondary outcomes

Study Arms (2)

transcutaneous electrical acupoint stimulation

EXPERIMENTAL
Device: transcutaneous electrical acupoint stimulation

Control

NO INTERVENTION

Interventions

Electrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given during surgery.

Also known as: TEAS
transcutaneous electrical acupoint stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years
  • scheduled for elective liver surgery under general anesthesia

You may not qualify if:

  • body mass index less than 18 kg/m2 or higher than 30 kg/m2
  • American Society of Anesthesiologists status higher than Ⅲ
  • patients with contraindication to transcutaneous electrical stimulation, including skin damage, infection or implantable electrical device
  • suspected or existed abuse of drug or alcohol
  • pregnant or breeding women
  • history of neurological or psychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lee A, Chan SK, Fan LT. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015 Nov 2;2015(11):CD003281. doi: 10.1002/14651858.CD003281.pub4.

    PMID: 26522652BACKGROUND

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The stimulator is put in an opaque box
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 25, 2022

First Posted

May 31, 2022

Study Start

May 30, 2022

Primary Completion

May 30, 2023

Study Completion

May 30, 2023

Last Updated

May 31, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share